Diabetes and hypertension are expected to drive the global prevalence of CKD, with much of this increasing burden observed in Asian locations of China and India.
Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report
Singapore - Novotech, the leading Asia Pacific centred biotech CRO has published
Read more